Skip to main content
Premium Trial:

Request an Annual Quote

Compugen Narrows Loss, Posts $90K in Revenues in Q4

NEW YORK (GenomeWeb News) – Compugen said today that it narrowed its fourth-quarter net loss to $3.1 million from $3.8 million in the fourth quarter of 2006. 
 
The company reported $90,000 in revenues for the quarter ended Dec. 31, 2007, compared to $10,000 for the fourth quarter of 2006. Revenues for both periods are from “small initial milestone payments under earlier agreements,” Compugen said.
 
Fourth-quarter net loss was $3.1 million, or $0.11 per share, compared with a net loss of $3.8 million, or $0.14 per share, for the prior-year period.
 
The net loss for Q4 2007 included a non-cash expense of $479,000 related to stock-based compensation, while the loss for the prior-year quarter included a non-cash expense of $523,000 related to stock-based compensation.
 
Compugen lowered its R&D spending by 30 percent to $2.8 million from $3.1 million in the fourth quarter of 2006. Sales and marketing expenses fell to $247,000 from $563,000 in the comparable period of 2006.
 
For full-year 2007, revenues fell by 16 percent to $180,000 from $215,000 in 2006.
 
Net loss for 2007 was $12.1 million, or $0.43 per share, compared with a net loss of $13.0 million, or $0.47 per share, for 2006.
 
R&D spending for the year was $9.7 million compared to $10.9 million for 2006, while sales and marketing costs were $1.3 million compared to $1.7 million.
 
As of Dec. 31, 2007, Compugen had $15.1 million in cash, cash equivalents, short-term deposits, and marketable securities.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.